NCT02145104View on ClinicalTrials.gov

Efficacy/Safety of Cilnidipine Plus Valsartan Versus Valsartan in Patients With Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

286

Participants

Timeline

Start Date

June 17, 2014

Primary Completion Date

June 7, 2016

Study Completion Date

September 29, 2016

Conditions
Hypertension
Interventions
DRUG

valsartan 160mg, cilnidipine 10mg, cilinidipine 5mg

Trial Locations (1)

Unknown

Seoul National University Bundang Hospital, Seongnam-si

Sponsors
All Listed Sponsors
lead

IlDong Pharmaceutical Co Ltd

INDUSTRY

NCT02145104 - Efficacy/Safety of Cilnidipine Plus Valsartan Versus Valsartan in Patients With Hypertension | Biotech Hunter | Biotech Hunter